|
Volumn 26, Issue 1, 1990, Pages 52-56
|
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
a a a a a b b a a c c c
b
Oncology Service
*
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DIDIMETHYLSULFOXIDE DICHLOROPLATINUM(II);
ETOPOSIDE;
MITOMYCIN;
PLATINUM COMPLEX;
MITOMYCIN C;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MORTALITY;
PROGNOSIS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SURVIVAL;
BLOOD TOXICITY;
CONTROLLED STUDY;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
COMPARATIVE STUDY;
ETOPOSIDE;
FEMALE;
HUMAN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGE;
MITOMYCIN;
MITOMYCINS;
ORGANOPLATINUM COMPOUNDS;
PROGNOSIS;
PROSPECTIVE STUDIES;
REMISSION INDUCTION;
SURVIVAL ANALYSIS;
|
EID: 0025195908
PISSN: 03445704
EISSN: 14320843
Source Type: Journal
DOI: 10.1007/BF02940294 Document Type: Article |
Times cited : (49)
|
References (17)
|